Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
New health care reform law includes patient safety provisions

New health care reform law includes patient safety provisions

Bioheart presents cutting edge therapies at 2010 Translational Regenerative Medicine Forum

Bioheart presents cutting edge therapies at 2010 Translational Regenerative Medicine Forum

Chocolate can lower blood pressure and reduce risk of heart disease: Study

Chocolate can lower blood pressure and reduce risk of heart disease: Study

Systemic treatment of microRNA therapeutic targeting miR-10b inhibits breast cancer metastasis

Systemic treatment of microRNA therapeutic targeting miR-10b inhibits breast cancer metastasis

NICE appraisal committee publishes preliminary recommendation of Multaq for AF

NICE appraisal committee publishes preliminary recommendation of Multaq for AF

StockPreacher.com announces investment report featuring ARCA biopharma

StockPreacher.com announces investment report featuring ARCA biopharma

Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation

Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation

Seniors with diabetes and dementia more likely to fall into Medicare Part D prescription drug plan

Seniors with diabetes and dementia more likely to fall into Medicare Part D prescription drug plan

Thomson Reuters' annual study identifying 100 top U.S. hospitals released

Thomson Reuters' annual study identifying 100 top U.S. hospitals released

ARCA biopharma granted patent for methods of treating heart failure patients with bucindolol based on genetic testing

ARCA biopharma granted patent for methods of treating heart failure patients with bucindolol based on genetic testing

Medical conditions put seniors at high risk of unsubsidized medical prescription expenses

Medical conditions put seniors at high risk of unsubsidized medical prescription expenses

Single-incision laparoscopy reduces postoperative complications

Single-incision laparoscopy reduces postoperative complications

Simultaneous implantations of BIOTRONIK's Lumax DX single-chamber ICD at six European hospitals

Simultaneous implantations of BIOTRONIK's Lumax DX single-chamber ICD at six European hospitals

Animal study shows chymase inhibitors could advance treatments for high BP and heart failure

Animal study shows chymase inhibitors could advance treatments for high BP and heart failure

Study on zebrafish regenerate tissues links human heart implications

Study on zebrafish regenerate tissues links human heart implications

Evotec AG reports financial results and corporate updates for 2009

Evotec AG reports financial results and corporate updates for 2009

High blood pressure lowers heart patients' death risk

High blood pressure lowers heart patients' death risk

Bioheart to open five centers to provide cell therapy procedures for congestive heart failure patients

Bioheart to open five centers to provide cell therapy procedures for congestive heart failure patients

Celladon Corporation receives USPTO notice of allowance covering MYDICAR for advanced heart failure

Celladon Corporation receives USPTO notice of allowance covering MYDICAR for advanced heart failure

CTI's pixantrone trial for relapsed/refractory aggressive NHL: FDA ODAC finds data inadequate for approval

CTI's pixantrone trial for relapsed/refractory aggressive NHL: FDA ODAC finds data inadequate for approval

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.